false
ar,be,bn,zh-CN,zh-TW,en,fr,de,hi,it,ja,ko,pt,ru,es,sw,vi
Catalog
Didactics
Endometrial Cancer
Endometrial Cancer
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In the video transcript, the speaker discusses the epidemiology and clinical management of endometrial cancer in high-income countries, particularly in Boston. Endometrial cancer is the most common gynecologic cancer in Boston, followed by ovarian and cervical cancer. The majority of endometrial cancers in Boston are type one, predominantly endometrioid cancers, which are estrogen responsive and usually have a good prognosis. Type two cancers, such as carcinosarcoma and clear cell cancer, are less common and have a lower survival rate. The staging of endometrial cancer is explained, and the speaker also mentions the use of neoadjuvant chemotherapy in advanced stage endometrial cancer. References to specific articles are provided, along with information about genetic features and potential molecular treatments for certain types of endometrial cancer.
Asset Subtitle
Thomas Randall
May 2022
Keywords
endometrial cancer
epidemiology
clinical management
Boston
neoadjuvant chemotherapy
Contact
education@igcs.org
for assistance.
×